We use cookies to give you a better experience on our website. Learn more about how we use cookies and how you can select your preferences.
Turning research evidence into clinical practice and better quality of care for patients
MRFF 2024 Rapid Applied Research Translation
What do you get?
A grant of between $250,000 to $5 million to cover up to 100% of eligible project costs.
Who is this for?
Eligible organisations that can support large-scale interdisciplinary research programs to improve health benefits for Australians.
About the program
The 2024 Rapid Applied Research Translation Grant Opportunity is part of the Medical Research Future Fund and the Rapid Applied Research Translation Initiative.
This initiative supports the translation of research evidence into clinical practice and better quality of care for patients by encouraging collaborations between academic researchers, health service providers, consumers and other end users on projects to improve health care delivery, service and systems sustainability.
Consistent with the Medical Research Future Fund Act 2015, the objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that:
- deliver late stage translational research that is directly relevant to clinical care, health services and/or health practices, which has the potential to be translated into existing policy and practice
- use existing knowledge and evidence to support and accelerate the translation of research findings into improved health care and health interventions
- address a clearly defined gap in best practice health care and health interventions to improve health outcomes, as identified by collaborating health services
- involve all stakeholders relevant to the research and its translation in its conceptualisation, design and implementation, including health care consumers and providers.
Two streams of funding are available:
- Stream 1 (Accelerator): the Chief Investigators are primarily resident in any area according to the Modified Monash Model (MM1-7)
- Stream 2 (Accelerator): the Chief Investigator A and 50% or more of all Chief Investigators are primarily resident in a regional, rural, or remote area according to the Modified Monash Model (MM2-7).
For this grant opportunity, an application may be submitted to one of the above two Streams only. Applicants must specify the Stream they are applying for in their application.
An organisation may submit more than one application to a single Stream, but there are restrictions on the number of applications an individual (i.e. Chief Investigator) may submit to a single Stream (refer the Section on Chief Investigators in the grant opportunity guidelines).
Past rounds
This opportunity is part of the Medical Research Future Fund (MRFF).
Contact
Need help?
Let us answer your question over the phone, email or live chat.
- Phone:
-
Open Hours:
Monday to Friday, 8am to 8pm across Australia
- Website:
Key documents
Board or CEO approval letter template
docx · 0.04 MBChief Investigator template - Stream one
xlsx · 0.84 MBChief Investigator template - Stream two
xlsx · 0.94 MBMRFF grant management resources
Reporting templates are available from the MRFF grants management webpage. The page also provides other resources for MRFF grant administration, including current policies and relevant forms and templates.
-
View the latest reporting templates on the MRFF grant management webpage.
Department of Health and Aged Care